Ikuo Tsunoda

Dr. Ikuo Tsunoda


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1996 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Closed access
PDF file
ITIkuo Tsunoda
Ikuo Tsunoda
RFRobert S. Fujinami
Robert S. Fujinami
In this review, we compare and contrast two popular models for multiple sclerosis (MS), Theiler's murine encephalomyelitis virus (TMEV) disease and experimental allergic encephalomyelitis (EAE). These models are used to investigate the viral and autoimmune etiology of MS, respectively. Infection with live TMEV is an essential component of TMEV demyelinating disease. TMEV-specific cellular and humoral immunity and apoptosis of infected cells eliminate virus from the gray matter of the central nervous system (CNS) during the acute phase of TMEV disease. In contrast, during the chronic phase, TMEV persistently infects glial cells and/or macrophages in the white matter. During the chronic phase, recruitment of macrophages, TMEV-specific T cells and antibody, with the induction, of apoptosis are harmful to the host, leading to inflammation and demyelination. In EAE, induction of encephalitogenic CD4+ T cells is an important component for disease. After stimulation and activation, these T cells upregulate adhesion molecules and are able to enter the CNS. Th1 cytokines augment the recruitment of mononuclear cells in the CNS. Macrophages and/or glial cells secrete cytotoxic factors leading to demyelination in conjunction with B cells secreting anti-myelin antibody. Although immunopathological pathways during the course of the demyelination in TMEV infection and EAE are not always the same, oligodendroglial apoptosis is observed in both models, suggesting that their demyelinating processes share a common terminal pathway and finally lead to quite a similar clinical and pathological picture.

1 November 2002 in Springer Seminars in Immunopathology
Verified
Journal Article
Closed access
PDF file
ITIkuo Tsunoda
Ikuo Tsunoda
RFRobert S. Fujinami
Robert S. Fujinami

1 February 1997 in Virology
Verified
Journal Article
Closed access
ITIkuo Tsunoda
Ikuo Tsunoda
CKCaroline I.B. Kurtz
Caroline I.B. Kurtz
RFRobert S. Fujinami
Robert S. Fujinami

6 November 2009 in Journal of Neuroimmune Pharmacology
Verified
Journal Article
Closed access
PDF file
ITIkuo Tsunoda
Ikuo Tsunoda
RFRobert S. Fujinami
Robert S. Fujinami

1 January 2006 in Autoimmunity
Verified
Journal Article
Closed access
LMLori McCoy
Lori McCoy
ITIkuo Tsunoda
Ikuo Tsunoda
RFRobert S. Fujinami
Robert S. Fujinami
Polymicrobial infections have been associated with plausible immune mediated diseases, including multiple sclerosis (MS). Virus infection can prime autoimmune T cells specific for central nervous system (CNS) antigens, if virus has molecular mimicry with CNS proteins. On the other hand, infection of irrelevant viruses will induce two types of cytokine responses. Infection with a virus such as lymphocytic choriomeningitis virus (LCMV), can induce interferon (IFN)-alpha/beta production and suppress autoimmunity, while infection with a virus, such as murine cytomegalovirus (MCMV), can activate natural killer (NK), NKT and dendritic cells, resulting in interleukin (IL)-12 and IFN-gamma production. These cytokines can cause bystander activation of autoreactive T cells. We established an animal model, where mice infected with vaccinia virus encoding myelin protein can mount autoimmune responses. However, the mice develop clinical disease only after irrelevant immune activation either with complete Freund's adjuvant or MCMV infection. In this review, we propose that a combination of two mechanisms, molecular mimicry and bystander activation, induced by virus infection, can lead to CNS demyelinating diseases, including MS. Viral proteins having molecular mimicry with self-proteins in the CNS can prime genetically susceptible individuals. Once this priming has occurred, an immunologic challenge could result in disease through bystander activation by cytokines.

1 April 2003 in The American Journal of Pathology
Verified
Journal Article
Closed access
ITIkuo Tsunoda
Ikuo Tsunoda
LKLi-Qing Kuang
Li-Qing Kuang
JLJane E. Libbey
Jane E. Libbey
RFRobert S. Fujinami
Robert S. Fujinami